在血中使用组织类型的血原激活剂诱导的血凝块溶解时间评估血中血摩杜林/血可激活的纤维溶解抑制剂的功能
Tetsumei Urano1,2, Yoshie Sano1, Yuji Suzuki3
1Department of Medical Physiology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Research and practice in thrombosis and haemostasis
|July 19, 2024
概括
可溶性血栓模块素 (sTM) /TAFI轴调节纤维解质. 再组合的sTM (rsTM) 激活TAFI,抑制凝块溶解,在血中足够的痕量sTM.
科学领域:
- 生物化学 生物化学
- 血液学 血液学 血液学
- 生理学 生理学 生理学
背景情况:
- 氨酸可激活纤维解酶抑制剂 (TAFI) 是纤维解酶的一个关键生理抑制剂.
- 在生理条件下,TAFI在调节凝块溶解中的确切作用需要进一步阐明.
研究的目的:
- 研究可溶性血栓模块素 (sTM) 和TAFI轴在控制纤维解中的调节作用.
- 评估重组sTM (rsTM) 对TAFI介导的血中凝块溶解调节的影响.
主要方法:
- 使用一种组织类型的血原激活剂诱导的血凝块溶解时间 (tPA-PCLT) 试验.
- 采用TAFIa抑制剂和rsTM来评估血中TM/TAFI系统的特定功能.
主要成果:
- TAFIa抑制显著缩短了tPA-PCLT,这表明TAFI的抑制作用.
- rsTM补充剂延长了tPA-PCLT,证明了其亲纤维解质作用,TAFIa抑制可以抵消这种作用.
- 来自接受rsTM治疗的患者的血显示了长时间的tPA-PCLT,对TAFIa抑制有反应,但没有进一步通过rsTM延长.
结论:
- TM/TAFI系统有效地调节了血中的纤维解质.
- 内源性sTM足以激活TAFI并抑制纤维素分解.
- 治疗剂量的rsTM激活TAFI,并在血环境中调节纤维素分解.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
668
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
668
Clot Retraction and Fibrinolysis
5.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.4K
Extrinsic and Intrinsic Pathways of Hemostasis
7.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.0K


